C16H14F3N5O
Neat
349.32
239807-03-5; Voriconazole, (R, R)-; H8VDB4S9ER; RefChem:1101025; 137330-52-0; rel-(R, R)-Voriconazole; (2R, 3R)-2-(2, 4-difluorophenyl)-3-(5-fluoropyriMidin-4-yl)-1-(1H-1, 2, 4-triazol-1-yl)butan-2-ol; (2R, 3R)-2-(2, 4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1, 2, 4-triazol-1-yl)butan-2-ol; rel-(2R, 3R)-2-(2, 4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1, 2, 4-triazol-1-yl)butan-2-ol; Voriconazole Impurity 7; (alphaR, betaR)-alpha-(2, 4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1, 2, 4-triazol-1-ylmethyl)-4-pyrimidineethanol; (R*, R*)-a-(2, 4-Difluorophenyl)-5-fluoro-ss-methyl-a-(1H-1, 2, 4-triazol-1-ylmethyl)-4-pyrimidineethanol (9CI); rel-(R, R)-Voriconazole; (2RS, 3RS)-2-(2, 4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1, 2, 4-triazol-1-yl)butan-2-ol; Voriconazole, (R, R)-rel-; 2XJK4399NE; orb2814735; SCHEMBL3713297; 2-(2, 4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1h-1, 2 and 4-triazol-1-yl)-2-butanol; Voriconazole USP Related Compound A; AKOS015854229; AKOS015895719
(2R, 3R)-2-(2, 4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1, 2 and 4-triazol-1-yl)butan-2-ol
InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16-/m1/s1